Namiko Ikeda

Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

Shingo Maeda, Tomoki Motegi, Aki Iio et al. · Journal for ImmunoTherapy of Cancer · 2022 · 45 citations · Full text

Medicine, Oncology, Urology +16

Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells

Shotaro Eto, Kohei Saeki, Ryohei Yoshitake et al. · PLoS ONE · 2019 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?

Yujin Kudo, Hisashi Saji, Yoshihisa Shimada et al. · European Journal of Cardio-Thoracic Surgery · 2012 · 35 citations · Full text

Medicine, Oncology, Surgery +14

Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma

Satoshi Kamoto, Masahiro Shinada, Daiki Kato et al. · Cells · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma

Masahiro Shinada, Daiki Kato, Satoshi Kamoto et al. · Cells · 2020 · 23 citations · Full text

Medicine, Cancer Biology, Oncology +14